Advent Capital Management’s Merck MRK Stock Holding History

Advent Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-105	Closed	-$5K	–	329
2018 Q2	$5K	Buy	+105	New	+$5.92K	﹤0.01%	270

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advent Capital Management's MRK Position: Q1 2025 in Review

Advent Capital Management sold out of Merck (MRK) in Q1 2025, closing a stake of 25,000 shares — an estimated $2.49M sold.

Advent Capital Management first reported a position in MRK in Q4 2016 and held it in 14 quarters. The position peaked at $9.77M in Q2 2018. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

Advent Capital Management reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
Advent Capital Management sold 25,000 Merck shares in Q1 2025, an estimated $2.49M.
Advent Capital Management first reported a position in Merck in Q4 2016 and held it in 14 quarters.
Advent Capital Management's Merck position peaked at $9.77M in Q2 2018.
3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Advent Capital Management's 13F filing for Q1 2025, filed 12 May 2025.